Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Frosst Canada LtdfiledCriticalMerck Frosst Canada Ltd
Priority to MYPI20041394priorityCriticalpatent/MY138681A/en
Publication of MY138681ApublicationCriticalpatent/MY138681A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
COMPOUNDS REPRESENTED BY FORMULA (I): OR A PHARMACEUTICAL ACCEPTABLE SALT THEREOF, ARE PHOSPHODIESTERRASE 4 INHIBITORS USEFUL IN THE TREATMENT OF ASTHMA AND INFLAMMATION AND USEFUL FOR THE ENCHANCEMENT OF COGNITION.